Skip to main content
Equibles

TRUIST FINANCIAL CORP

Position in PRQR — ProQR Therapeutics N.V.

CIK 92230 CHARLOTTE, NC
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$18,600
+$2,400 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 69 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TRUIST FINANCIAL CORP holds $119,351,579 across 51 Biotechnology names. PRQR ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 106,967 $53,133,716
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,731 $24,150,326
3 ARGX
Argenx SE
 3,790 $3,516,247
4 EXEL
Exelixis, Inc.
 63,541 $3,457,265
5 URGN
UroGen Pharma Ltd.
 72,286 $2,660,124
6 JAZZ
Jazz Pharmaceuticals plc
 10,121 $2,438,856
7 VCEL
Vericel Corp
 51,315 $2,283,003
8 RPRX
Royalty Pharma plc
 29,890 $1,675,931

All Filings in PRQR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,600 10,000
2026-03-31 $16,200 10,000
2025-12-31 $20,200 10,000
2025-09-30 $21,300 10,000
2025-06-30 $20,400 10,000
2025-03-31 $13,300 10,000
2024-12-31 $26,500 10,000
2024-09-30 $18,200 10,000
2024-06-30 $16,600 10,000
2024-03-31 $22,900 10,000
2023-12-31 $19,800 10,000
2023-09-30 $13,000 10,000
2023-06-30 $16,200 10,000